Back to top

Buy Rating on Valneva Supported by Promising Vaccine Developments and Solid Revenue Projections

Analyst Edward White of H.C. Wainwright reiterated a Buy rating on Valneva (VALN – Research Report), with a price target of $26.00. Edward White ha...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Valneva SE Sponsored ADR (VALN)